|
|
|
|
|
|
Kura Oncology Cmn (KURA)
|
|
8.50 +0.65 (+8.28%)
|
6/26/2017 2:53pm
|
|
Open:
|
7.70
|
Pre. Close:
|
7.85
|
|
High:
|
8.60
|
Low:
|
7.50
|
|
Volume:
|
61,686
|
Market Cap:
|
167.17M
|
|
|
|
Stock Price Prediction (Update at 5:00pm est.)
|
|
If
tomorrow:
|
Open
lower
|
Open
higher
|
|
High:
|
8.59 - 8.75
|
8.75 - 9.22
|
|
Low:
|
6.84 - 6.93
|
6.93 - 7.19
|
|
Close:
|
7.55 - 7.79
|
7.79 - 8.49
|
|
|
|
|
|
|
Technical analysis (as of: 2017-06-26 2:30:58 PM)
|
|
Overall:
|
|
|
Stoxline posted a BUY today, same as yesterday. This stock seems to continue bullish move. If you bought, continue to hold stock until SELL signal. You are relatively safe to buy now, upward move is expected.
|
|
Target:
|
Six months: 10.53 One year: 11.91
|
|
Support:
|
Support1: 7.10 Support2: 5.91
|
|
Resistance:
|
Resistance1:
9.02 Resistance2: 10.20
|
|
Pivot:
|
7.94 
|
|
Moving Averages:
|
MA(5): 7.73  MA(20): 8.21
MA(100): 8.59 MA(250): 6.60
|
|
MACD:
|
MACD(12,26):
-0.35 Signal(12,26,9): -0.40
|
|
%K %D:
|
%K(14,3): 46.83 %D(3): 29.03
|
|
RSI:
|
RSI(14): 51.83
|
|
52-Week:
|
High: 12.10
Low: 2.50 Change(%): 214.8
|
|
Average Vol(K):
|
3-Month: 114
10-Days 204
|
|
|
★
Strong Sell
★★
Sell ★★★
Neutral
★★★★
Buy
★★★★★
Strong Buy
|
|
|
Price, moving averages and
Bollinger Bands
|
|
Price and moving averages has closed above its Short term moving average. Short term moving average is currently below mid-term; AND below long term moving averages. From the relationship between price and moving averages; we can see that: This stock is NEUTRAL in short-term; and NEUTRAL in mid-long term.KURA has closed below upper band by 19.8%. Bollinger Bands are 12.3% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.
|
|
|
Headline News
|
|
Mon, 26 Jun 2017 11:26:15 GMT
Kura Oncology Added to Russell 3000® Index
Tue, 27 Oct 2015 00:59:41 GMT
7.85
Sat, 31 Oct 2015 14:25:16 GMT
Kura Oncology Inc. KURA (US: Nasdaq)
Mon, 30 Mar 2015 15:01:06 GMT
Kura Oncology's Menin-MLL Inhibitor Program Shows Promise in Study Published ...
Mon, 15 May 2017 23:26:15 GMT
Kura Oncology's (KURA) CEO Troy Wilson on Q1 2017 Results - Earnings Call ...
|
|
|
Financial Analysis
|
|
Growth
|
|
|
Growth measures the growth of both a company's revenue
and net income. it tells investors how fast a company is growing.
|
|
Profitability
|
|
|
Profitability measures a company’s ability to
generate earnings as compared to its expenses
and other relevant costs.
|
|
Solvency
|
|
|
Solvency measures a company's ability to meet its long-term debts.
Acceptable solvency ratios will vary from industry to industry.
|
|
Efficiency
|
NA
|
|
Efficiency measures the strength of a company's return on invested capital.
It can identify business that are better managed or not.
|
|
Click here to get more fundamental analysis.
|
|
